Stocks To Buy Now Blog

All posts by Christopher

The Digital Assets: Exploring The Metaverse And Crypto Assets Conference Powered by M-Vest Events to be held on June 23

Issuers, investors, members of executive management, thought leaders, and individuals well-versed in the digital assets space are invited to attend the conference on Digital Assets: Exploring The Metaverse And Crypto Assets (“Digital Assets Conference”), being held on June 23, 2022, as a wholly online, virtual event. This event will showcase presentations and commentary from innovative emerging companies and industry leaders in key focus areas including bitcoin, NFTs, other digital assets, emerging regulations, and the metaverse. The Digital Assets Conference is a world-class event organized by M-Vest, a division of the Maxim Group LLC, a leading full-service investment bank, securities, and wealth management firm. M-Vest provides access to online investment opportunities and a digital community for issuers, investors, and thought leaders to share information, discuss capital raisings and garner market insights on current market trends. The event will host virtual panel discussions with leading executive management2222 teams from public and private companies, moderated by seasoned research analysts at Maxim Group. The Digital Assets Conference also facilitates engagement with a lively and dynamic investor community and provides participating attendees access to live events and insightful Q & A sessions. As a result, emerging companies will have the opportunity to connect with veteran investors, achieve recognition and broaden their networks. At the Digital Assets Conference, session themes include Exchanges, Mining, Gaming/Metaverse, NFT – Platforms, and NFT – Creative. Panel discussions will tackle a wide variety of industry aspects including the impact of rising rates on the value of bitcoin; NFTs, and other digital assets; future market opportunities; and development around collectibles and gaming; emerging regulation around crypto-assets and trading; as well as the application of NFTs and the metaverse to personal identity. Panelists will include industry experts from prominent private companies such as Crosstower, Pink Panda, Qenta Inc., Poolin, NFTSTAR, and Loot NFT Co. Marquee public companies in attendance are Digihost Technology, LM Funding America, Sphere3D and many more across a wide gamut of sectors. Hurry and reserve your seat at MVest events!

Green Solutions Advanced by Correlate Infrastructure Partners Inc. (CIPI) Foreshadow Major Economic Revolution in Energy Efficiency

  • Global efforts to address climate change are expected to drive an economic market that Special Presidential Envoy for Climate John Kerry argues will ultimately be larger than the Industrial Revolution was
  • While energy efficient commercial buildings have rapidly increased in the United States and Canada during recent years, the mission of sustainability must be spread among construction and development professionals.
  • Green energy solutions company Correlate Infrastructure Partners Inc. is helping companies reduce their carbon footprint through it’s data-centric platform for analyzing corporate facilities’ energy usage and spearheading their sustainability solutions
  • Correlate’s services make it possible for companies to be apart of the solution by achieving greater energy efficiency and access to locally sited solar, energy storage and EV infrastructure
While climate change worries have been expressed as a threat to future life, Special Presidential Envoy for Climate John Kerry recently cast a more optimistic vision of the potential that climate change represents in terms of economic possibilities. “This is the largest market the world has ever been staring at: the energy transition market,” Kerry told attendees at the IV CEO Summit of the Americas in Los Angeles on June 9 (https://ibn.fm/4IbtG). “Every aspect of life can be impacted in a positive way. It’s not something to fear — that we have to shun and shy away from. We have to embrace this transition which will, in the end, I guarantee you, be larger than ultimately than the Industrial Revolution was.” Louisiana-based Correlate Infrastructure Partners (OTCQB: CIPI) is a purpose-built energy use optimization company pursuing green utilities solutions for the commercial real estate industry. They are innovating the industry with the mission of sustainability, and the kickback of increased net operating income. The company is one of many whose enthusiasm mirrors Kerry’s faith in the idea that finding solutions for reducing carbon emissions is sound business sense. “Correlate Infrastructure Partners is making energy management and procurement transparent and cost-effective as we digitize the process that has been archaic for way too long. We are excited to be at the forefront of an industry that is at an inflection point, and we are eager to begin working to change the way commercial real estate owners optimize energy assets,” CEO Todd Michaels stated last month. The company uses proprietary data analysis and concierge services to help facilities owners and construction professionals evaluate and improve their energy usage footprints, providing the necessary information to work through what Utah’s Clean Energy authorities branded a “net-zero learning curve” (https://ibn.fm/0yApb). Media outlet CleanTechnica recently reported on data published by the journal iScience, showing that “the people operating renewables like solar and wind farms are learning to do so more efficiently, lowering the levelized cost of electricity (‘LCOE’)” and financing rates for related assets (https://ibn.fm/FF6ug). According to the researchers, LCOE refer ?s to cost metrics spread across the lifetime of an operation, and in regard to the wind energy market the average cost per megawatt-hour (“MWh”) fell from $440 when the market launched in 1982 to $32 in 2020 — a reduction of 93 percent. The LCOE for utility scale solar energy fell from $230 per MWh when it began in 2007 to $34 per MWh in 2020 — a rapid 85 percent decline. The news is encouraging to those striving to reduce carbon dioxide emissions. The Statistics Division of the United Nations has reported that for the terms outlined in the Paris Accords seven years ago to be accomplished, global CO2 emissions must be cut to 55 percent of their 2010 levels by 2030 and reach net-zero by 2050 (https://ibn.fm/wNUco). For more information, visit the company’s website at www.CorrelateInfra.com, including the following: NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Growing its Retail Footprint and Creating Value for Shareholders

  • Eat Well Investment Group has focused on expanding its product offerings, targeting both small and large businesses, and has successfully grown its retail footprint with the addition of notable retailers in both the U.S. and Canada
  • Its aggressive expansion has seen Eat Well serve customers in over 35 countries, with projected revenue of $100 million in 2022
  • The company is confident that, with current opportunities in the plant-based sector, it will achieve its 2022 revenue target and create value for its shareholders
At the close of the 2021 calendar year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) announced the appointment of Marc Aneed as its new Chief Executive Officer (“CEO”). Mr. Aneed, having taken over from retiring David Doherty, assured investors that the company would also remain focused on driving shareholder value into 2022 and beyond (https://ibn.fm/bbreb). Under his leadership, Eat Well Investment Group has disrupted the multi-billion snack food market. In addition, it has fortified its vertically integrated approach to feeding people delicious, more nutritious food, at a lower cost. The company also completed strategic acquisitions, most notably, Sapientia. In addition, Eat Well closed a strategic investment from Nurture Health Food LLP. Mr. Aneed notes that this investment will be integral to the company’s international growth while setting the stage for further collaboration (https://ibn.fm/4U687). Eat Well’s aggressive expansion under Mr. Aneed’s leadership would also see the company announce that its majority-owned portfolio company, Amara Organic Foods, would be available in approximately 200 HEB Grocery Company, LP locations across the U.S. within the first quarter of the 2022 fiscal year. The additional distribution added to Amara’s strong retail footprint, which comprised Walmart Canada, Whole Foods, Costco, Sprouts Farmer’s Market, Sobeys, and Loblaws. In June, Eat Well announced the addition of another distributor to its roster – The Kroger Co. While making the announcement, Eat Well noted that Amara Organic Foods would now be available on The Kroger Co.’s eCommerce platforms, a welcome addition to Amara’s omnichannel sales distribution strategy (https://ibn.fm/55cfm). “Increased distribution through eCommerce channels continues to be a strategic focus of Amara to drive both topline revenue and to maximize margins that come from a DTC environment,” noted Jessica Sturzenegger, Amara’s CEO. Eat Well now has customers in over 35 countries. With $57.9 million (Canadian) in revenue posted in 2021, the company is confident that, with the added distribution channels and partners, its portfolio will achieve approximately $100 million in revenue in 2022. This target will also be achieved by Eat Well’s plan to upgrade and expand its production facilities to meet demand increases through its portfolio company, Belle Pulses. In 2021, Belle produced approximately 90,000 metric tons of protein. With the recent spike in global demand, fueled by Russia’s invasion of Ukraine, Belle has announced plans to increase shifts at its main plant in Saskatchewan to increase Canadian annual production capacity to nearly 100,000 metric tons annually. In addition, the company will also add up to an additional 15,000 metric tons per year of annual production capacity at its United States facility (https://ibn.fm/Aurer). “Belle is receiving increased recognition from international customers looking to secure quality, safe and reliable proteins at scale,” noted Mark Coles, Eat Well’s Chief Investment Officer (“CIO”). “Shareholders should know that Belle is increasing its production capacity as it is our goal to help support the global food industry. We will continue to expand Belle’s operations and are looking forward to showing the world its ability to procure, process, and deliver proteins to the international marketplace,” he added. With the growing demand for food, given current global supply chain interruptions and the growing potential of the plant-based sector, Eat Well Investment group is optimistic that its future is bright. Through its strategic investments and partnerships with key distributors in the industry, the company is confident that it will achieve its 2022 revenue targets while also creating tremendous value for its shareholders. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

Friendable Inc.’s (FDBL) 360-Degree Artist Platform Fan Pass Live Pushes Other Music Distribution Platforms to Change Stale Pricing Structure and Offer Independent Artists More Support

  • The majority of music industry revenue is not distributed to artists but to the labels and distribution companies that own them
  • Friendable’s flagship offering, in conjunction with the recently acquired Artist Republik and FeaturedX, offers artists a 360-degree platform for music creation, distribution, and marketing – a one-of-a-kind experience
  • TuneCore announced that it would be changing its pricing structure, making it more affordable for musicians looking to distribute their music on their own, but has not changed offering to include all of the Fan Pass Live solutions
In the past, artists looking to distribute their music had very few options, and these options were often linked to a relationship with a record label. In 2018, Rolling Stone published an article about how much musicians bring home from the revenue earned in the music industry – 12%. That is not 12% per musical artist, but the industry as a whole. At that time, the industry was valued at $43 billion across on-demand streaming, CD sales, radio play, live events, and advertising. Still, artists only shared a small portion of these earnings ($5 billion) (https://ibn.fm/S0TSp). One of the biggest pain points faced by independent music artists in the industry today is the high cost associated with creating, distributing, and marketing their music. In July 2020, Friendable (OTC: FDBL) released the Fan Pass Live artist platform and has since grown exponentially, increasing the number of artists and acquiring Artist Republik and FeaturedX in January 2022. Combined, Fan Pass Live now offers a 360-degree artist platform that embraces creation, distribution, and marketing – minus label control, in what can be described as an “anti-label” movement. The Fan Pass Live offering benefits both artist and fan, creating a space for live performances and exclusive content, community discussion, and more. Artists receive 100% revenue from ticket sales and tips, in addition to monthly contests and other revenue streams, with more coming soon to include NFTs and Metaverse performances. No other company currently offers a 360-degree solution for artists, like Fan Pass Live. Many only focus on production and others on distribution or marketing – not all-in-one like Fan Pass Live. Other music distribution services are feeling the pressure from Fan Pass Live’s total embodiment of the independent artist experience, changing pricing structures to be more in line with what is being offered elsewhere. For example, the biggest announcement in 16 years for music distribution service TuneCore came last week when the company announced that it would change its subscription pricing structure. “We’ve spent a year speaking directly to artists and labels about how we can make our service better for them. What emerged is: artists want to be able to test their new music for free before distributing to all services, and they want to release the music they are creating instantly, regularly, and seamlessly with one annual subscription enabling unlimited music distribution,” Andreea Gleeson, TuneCore CEO, stated (https://ibn.fm/Afiuy). “TuneCore’s new program gives self-releasing artists at any stage of their careers the freedom to choose the plan that works best for them, while maintaining the high quality of service TuneCore is known for. With TuneCore Unlimited, artists pay less and earn more.” Despite the changes in TuneCore’s subscription, artists still gain more when using Fan Pass Live’s 360-degree artist platform with options for one-time or subscription distribution services with no annual fees and 100% of royalties paid to the musician. In addition to low pricing, Fan Pass Live’s promotion offering includes social links, playlisting, PR, radio promo, distribution, ticketed live streaming, and much more – a list unmatched in the industry and unattainable by TuneCore despite changing their pricing structure. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Lexaria Bioscience Corp. (NASDAQ: LEXX) Initiates Communication with the FDA Concerning Potential Treatment for Hypertension; Out-Licenses Its DehydraTECH Technology to International Markets

  • Lexaria, a global innovator of drug delivery platforms, recently filed a pre-IND meeting request letter with the FDA, initiating communication regarding the development of its DehydraTECH-CBD as a treatment for hypertension
  • The company has been undertaking preparatory programs in readiness for the meeting, as well as an IND application filing
  • The pre-IND meeting will confirm the details of the company’s IND-enabling program
  • Lexaria also announced it had licensed its DehydraTECH technology to AnodGen, with the announcement following similar out-licensing agreements with Valcon Medical and Premier Science
Early last September, global innovator Lexaria Bioscience (NASDAQ: LEXX) was pleased to announce it had formally commenced the process toward an Investigational New Drug (“IND”) application filing with the Food and Drug Administration (“FDA”) with its DehydraTECH(TM)-processed cannabidiol (“CBD”) for the treatment of hypertension (https://ibn.fm/WQFnA). According to the September 8 news release, Lexaria had retained the services of an expert regulatory affairs and quality assurance consulting group that would help prepare the company for a pre-IND meeting with the FDA. The group would also assist Lexaria with designing the requisite non-clinical, clinical, and related product development IND-enabling work/program meant to be finalized before the company files its IND application. Through the intervening period, Lexaria has made progress bringing it closer to achieving these goals, recently reporting it had filed a pre-IND meeting request letter with the FDA. The request, to which the federal agency had already responded and set a target date of July 30, 2022 (subject to the fulfillment of certain conditions), formally initiated communication with the FDA concerning the development of DehydraTECH-CBD as a treatment for hypertension (https://ibn.fm/PoR5K). “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” commented Lexaria President John Docherty. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.” The pre-IND meeting is intended to confirm the details and acceptability of Lexaria’s IND-enabling work, which is set to be completed after the meeting has been held. This work has been made possible by the company’s growing body of evidence showing DehydraTECH-CBD’s capacity to potentially treat hypertension. Through its successfully completed studies – HYPER-H21-1, HYPER-H21-2, and HYPER-H21-3 – Lexaria has not only demonstrated that DehydraTECH-CBD lowers the human blood pressure relative to placebo and reduces arterial stiffness but also that it does not cause any adverse effects. According to the company’s recent statement, efficacy and the lack of negative side effects are the two main goals of FDA-registered clinical studies. Following the pre-IND meeting and the completion of the IND-enabling development program, Lexaria expects to then proceed with its full IND application filing expected in late 2022 or early 2023. Meanwhile, the company also celebrated another milestone that saw it expand the list of licensees. In a recent announcement, Lexaria reported that its wholly owned subsidiary, Lexaria Pharmaceutical Corp., had awarded a five-year, non-exclusive DehydraTECH license to AnodGen Bioceuticals of Ireland (https://ibn.fm/RxIVe). The license allows AnodGen, a newly established contract manufacturing organization business, to manufacture and distribute DehydraTECH-processed cannabinoid active pharmaceutical ingredient (“API”) powders within Europe (including the UK), Australia, and New Zealand. The license also covers pharmaceutical and medical product applications for psychoactive cannabinoids and medical product applications for non-psychoactive cannabinoids. AnodGen can also manufacture and sell the API powders to third-party companies for their own products, subject to the fulfillment of specific conditions. On its part, Lexaria will receive royalty fees for all API powders sold that utilize the DehydraTECH drug delivery technology. This licensing agreement comes on the heels of two similar agreements that saw Lexaria Pharmaceutical Corp. grant a European and UK license to medical cannabis manufacturer Valcon Medical A/S (https://ibn.fm/atOS7) and a license to Premier Wellness Science Co. Ltd to deploy DehydraTECH within the Japanese non-pharmaceutical market (https://ibn.fm/ALjfa). “We are focused on larger national and international applications for DehydraTECH, primarily but not entirely in the pharmaceutical sector. These are our areas of interest that we expect will provide significant revenue streams over time…,” commented Lexaria CEO Chris Bunka in a January letter to shareholders (https://ibn.fm/cZwn3). With the series of out-licenses announced recently, Lexaria appears to be inching closer to realizing this goal. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Set to Capitalize as Canada’s Industrial Sector Rushes to Adopt Renewable Energy

  • Canada’s federal carbon tax recently hit a record $50/ton, helping fuel a veritable gold rush within the domestic carbon credit industry
  • The move has simultaneously sparked a mass rush amongst Canadian industrial players to transition towards renewable energy sources, with renewable natural gas (“RNG”) top of the list
  • EverGen Infrastructure has become a key player within the Canadian RNG sector, with three active processing plants within British Columbia, and development underway in Alberta and Ontario
  • The company recently acquired a 50% stake in an Ontario-based RNG development, a move which will see the company boost its cumulative production capacity to upwards of 1 million gigajoules per annum
A European energy broker recently reached out to Base Carbon, a Canadian-listed carbon credit-focused investment fund (https://ibn.fm/t3xZW). The motive for the call? The broker was seeking to sell a portfolio of carbon credits generated in 2015 by a Chinese wind farm operation. Canada’s federal carbon tax hit a record $50/ton in April 2022 – effectively penalizing companies on account of their carbon footprint. That in turn has sparked a veritable ‘gold rush’ within the Canadian carbon credit industry, with hordes of companies actively seeking to mitigate their carbon emissions. Simultaneously however, it has also driven home the need for an ever-increasing number of companies to begin adopting renewable natural gas (“RNG”) as a core energy feedstock (https://ibn.fm/Nz6cN). EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), a British-Columbia based renewable natural gas operator, is set to be a key beneficiary of this trend. The ongoing move towards adopting renewable energy sources was best enunciated by Modern Niagara, a Canadian integrated building contractor, which has set a carbon reduction goal of 30% by 2030. “We had corporate sustainability goals. While discussing those goals, we were wondering how we’d change our 2030 and 2050 mandates, and RNG was brought forth to us as a carbon reduction solution and we saw an opportunity to acquire a bunch of RNG and provide it back to our clientele base,” stated Stefan Ritchie, Modern Niagara’s new business development manager. “We all have to adhere to reduction goals set by the federal government, and if we don’t, we’ll be levied with larger carbon taxes,” he concluded. EverGen has sought to cater to the growing demand for renewable natural gas, aggressively growing its supply capabilities in recent years. In addition to the company’s ownership of Fraser Valley Biogas, Western Canada’s first RNG facility which has been in continuous operation since 2011, EverGen also manage two composting and organic processing facilities, which seek to combine anaerobic digesting and biogas upgrading technologies to produce RNG from the manure generated by local dairy farms. More recently, EverGen Infrastructure revealed that the company had purchased a 50% stake in a portfolio of renewable natural gas development projects in Ontario, Canada from Northeast Renewables (https://ibn.fm/QZXw2). The deal, which saw EverGen pay a gross cash consideration of $1.5 million, has a targeted cumulative production capacity of approximately 1.7 million gigajoules (“GJ”) per year, with the projects set to be constructed in 2023 and 2024. Ultimately, EverGen expects the Ontario-based project to more than triple its RNG capacity to upwards of 1 million GJ per year. EverGen CEO Chase Edgelow commented in regard to the deal: “The acquisition of Project Radius provides a foothold in Ontario, a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects.” Canada’s historically fossil-fuel dependent industrial sector has gradually begun to embark on a transition towards renewable energy sources to both, reduce their carbon footprint whilst simultaneously, shielding their bottom-line from ever increasing carbon taxes. As a leader in the domestic RNG industry, EverGen is seeking to provide them with the sustainable infrastructure needed to fuel that change. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

Golden Matrix Group Inc. (NASDAQ: GMGI) Leverages AI-Powered Platform to Maximize Online Gaming Profits

  • iGaming customer acquisition costs rising, reducing operator profitability
  • GMGI offers AI-powered iGaming software that provides partners with customer data that boosts monetization strategies, increases player retention
  • System generates skill and game-preference data that enables operators to offer incentives that prolong activity and increase returns
Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, leverages the power of AI to maximize profits for its growing B2B customer base. The company offers highly modular, configurable, turnkey, and white label gaming platforms that are compatible with all major browsers, operating systems, and devices.  With a focus on maximizing value for partner companies, GMGI integrates AI-powered tools into their systems that facilitate user acquisition, engagement, retention, and monetization. Customer acquisition cost is a primary factor driving growth and market share acquisition for iGaming businesses. According to Enteractive, an iGaming marketing company, costs to acquire a player range from $280 to $1400 per customer (https://ibn.fm/lhYqn). At the same time, advertising costs such as pay-per-click (“PPC”) are rising rapidly, creating profitability concerns in an increasingly saturated market. Golden Matrix offers AI-powered solutions that provide a substantial competitive advantage to their partners, enabling them to boost revenues and increase customer retention. “We provide the tools that change their world,” said Golden Matrix CEO Brian Goodman in a recent interview (https://ibn.fm/5ekQb). “Often people say to me, ‘What makes you different from other systems?’…well the difference is in our loyalty systems…our products provide these tools, artificial intelligence, loyalty tools, bonus and free spins. “Once you pay all this money for a client, then you better ensure you have these tools to get this money from these clients because what you have is much more powerful than a land-based situation. You have a computer or an iPhone in somebody’s living room and you’ve got a lot of information on these people. What happens is that you use these tools to determine what the player skill levels are, how long they spend in the casino, what they like to play. All of these items or pieces of marketing that we provide in our system is critical to survival.” GMGI’s AI-powered tools are built into their GM-X Turnkey, GM-X White Label, and GM-X Direct Integration solutions. GM-X Turnkey is a complete software package that integrates thousands of games from leading content providers and includes a full suite of tools that allow operators to operate and maintain an online gaming website. The company’s GM-X White Label solution enables operators to start an online gaming platform from scratch with licensing, accounting, management, support, and gaming content. GMGI’s GM-X Direct Integration Solution provides complete access to the company’s gaming portfolio and acts as an integration layer between the operator and content provider on top of the GM-X aggregation system. Golden Matrix Group is the leading provider of turnkey and white label gaming platforms, Esports technology, and gaming content. The company pioneers highly modular, configurable, and scalable AI-powered gaming platforms that work on all major operating systems and devices, offering partners a distinct competitive advantage in the iGaming industry. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

Speculation of Bear Market Reinforced by Crypto Declines and Cutbacks

  • Bitcoin reached an all-time low of $22,725 since December 2020
  • Other cryptos are feeling the strain, many of which are facing value declines of more than 30% in just a week
  • Many crypto-focused companies have begun issuing hiring freezes and layoffs as a result of the low-valued prices
  • Crypto exchange Gemini is laying off at least 10% of its employees, citing a turbulent market and “crypto winter”
Speculation of a bear market has become a reality. Bitcoin just reached an all-time low (since December 2020), with a value of $23,981. Other cryptocurrencies are feeling the effects of this bear market as well, with the total cryptocurrency market cap declining to $1.02 trillion as of June 13, 2022, from $3 trillion in November 2021. According to Antoni Trenchev, co-founder and managing partner of crypto lending platform Nexo, “Cryptos remain at the mercy of the Fed and stuck in a merry dance with the Nasdaq and other risk assets. We’re hearing Bitcoin forecasts in the mid-teen, and single-digit thousands, which tells you the type of macro environment crypto is facing for the first time — and the levels of fear” (https://ibn.fm/CPMCz). Crypto-focused companies like Canaan, Inc. (NASDAQ: CAN), a developer of digital blockchain computing equipment, saw declines in excess of -13%. Canaan’s short-term technical score of 46 has indicated that the stock has traded less bullishly over the last month than 54% of the stocks on the market. Canaan’s long-term technical rank is 56, meaning that over the last 200 trading days, the company ranked within the top half of stocks. In the Computer Hardware Industry, Canaan’s score is 76, ranking better than 76% of stocks. Canaan is scheduled to release their earnings statement in August 2022. In light of the recent decline, traders are betting for a more aggressive pace of Federal Reserve tightening since data last week shows inflation soaring to a 40-year high in May. Crypto has struggled immensely under the Fed’s policy in recent months, and that struggle has hit some companies hard. For example, the collapse of the Terra/Luna ecosystem last month. Confidence in the crypto space is critically low right now. Bobby Ong, co-founder and Chief Operating Officer of CoinGecko, expressed a warning on Twitter, “From the next cycle’s view, we are probably near the bottom, but that doesn’t mean that price can nuke 50% further. FWIW, I don’t think we are at the bottom yet coz conferences are still full, crypto parties are still extravagant, still seeing excesses among teams, macro environment is still weak. The layoffs have started but not widespread yet. Stay strong and manage your positions well” (https://ibn.fm/dPV3z). With the tumbling prices that have occurred this year in the crypto industry, some of the trading platforms, including Coinbase Global Inc. (NASDAQ: COIN), have begun instituting hiring freezes and layoffs. The crypto exchange Gemini announced recently that 10% of jobs would be eliminated. The Gemini announcement came from Cameron and Tyler Winklevoss, citing the “turbulent market conditions” as a determining factor. “This is where we are now, in the contraction phase that is settling into a period of stasis — what our industry refers to as ‘crypto winter.’ This has all been further compounded by the current macroeconomic and geopolitical turmoil. We are not alone,” the Winklevoss brothers said (https://ibn.fm/MWokd). The current crypto climate further supports the consensus that the market is now in bear territory.

Odyssey Health, Inc. (ODYY) Moving to Fill Gaps in Treatment and Management of Concussion Among Military Service Members

  • Odyssey is a medical company developing PRV-002, a novel compound for the treatment of concussion
  • Between 75-83% of all the cases of traumatic brain injury (“TBI”) among U.S. service members have been classified as mild (“mTBI”), commonly termed “concussion”
  • Although concussion greatly impacts the military, there are significant gaps in the understanding of the optimal diagnostic, treatment, and management criteria
  • Odyssey is looking to bridge this informational gap with its clinical trial and intends to start its U.S. Phase II trials at military training sites, subject to the FDA’s approval of the results of its Phase I study
The Center for Disease Control (“CDC”) notes that more than 430,000 U.S. service members were diagnosed with a traumatic brain injury (“TBI”) between 2000 and 2020 (https://ibn.fm/6Yycd), with 75-83% of all these cases being mild (“mTBI”), according to different studies (https://ibn.fm/0MQas). These statistics make mTBI, also known as concussion, the most common TBI affecting military personnel. But despite its prevalence, mTBI is the least understood and most difficult to diagnose of the different forms of TBI and has been a largely unexplored area of medical intervention until very recently. In military settings, head injuries caused by shock waves from explosives, violent impact, or ballistic penetration are cited as the main causes of TBI, with most concussions resulting from blunt trauma. While symptoms from a concussion are “usually self-limited and resolve spontaneously over a period of a few weeks, 10-15% of individuals develop prolonged symptoms or postconcussive syndrome (‘PCS’)… Neuropsychological testing in PCS may reveal persistent, yet subtle cognitive deficits, often in the executive domain” (https://ibn.fm/kRQxc). “Despite the impact that concussion has on military service members, significant gaps remain in our understanding of the optimal diagnostic, management, and return to activity/duty criteria to mitigate the consequences of concussion. Specifically, there is insufficient evidence supporting the objectivity (i.e., sensitivity and specificity) of our assessment measures, the optimal treatment strategies to mitigate the impact of concussion, and our ability to predict longer-term outcomes following injury,” writes a 2020 journal article (https://ibn.fm/bjkKe). This is despite the enactment of the Traumatic Brain Injury Act of 2008, which, among other things, mandated state traumatic brain injury surveillance systems, including the CDC and the Department of Defense (“DoD”), to link individuals with TBI to services and supports (https://ibn.fm/z3jnu). Even more concerning, there is currently no FDA-approved treatment for concussion. In understanding the severity of concussion among service members and the existing gaps in concussion treatment, Odyssey Health (OTC: ODYY) is working to develop treatments for concussion and other neurological disorders. Odyssey is developing the PRV-002, a novel, fully synthetic, non-naturally occurring neurosteroid for the treatment of concussion that is the subject of ongoing Phase I clinical trials. PRV-002 has undergone preclinical studies, which suggest that the drug has “equivalent, and potentially superior, neuroprotective effects compared to related neurosteroids. In animal models of concussion, PRV-002 reduced the behavioral pathology associated with brain injury symptoms such as short-term memory loss, depression/anxiety-like behavior, motor-sensory impairment” (https://ibn.fm/XYRCk). Last fall, Odyssey received international approval to start Phase I human clinical trials (https://ibn.fm/y0nAN) designed to test for drug safety, tolerability, and concentration in both the urine and blood as dosing increases. The Phase I trials comprise 40 healthy subjects segmented into five cohorts, each with eight participants. Odyssey and its research partners will report and approve trial data for continuation after each cohort is completed, with the next group receiving an increased dose if no abnormalities are observed in the preceding cohort. Data from a recently completed safety evaluation of cohort I revealed that PRV-002 is well-tolerated, meaning no severe adverse events were noted. Encouraged by the positive results from the preclinical and the ongoing Phase I study, Odyssey has set sights on Phase II clinical trials in the U.S., which will initially focus on the military. “Based on our animal data and after reviewing our initial Phase I trial safety reports, we are optimistic that PRV-002 will be a safe option for the treatment of concussion. We look forward to completing the Phase I trial and presenting our findings to the FDA. Following FDA review, we intend to initiate a Phase II clinical trial in the U.S., starting with our military. We have created a military advisory board to assist with this effort,” commented Odyssey CEO Michael Redmond in a May 5 news release announcing positive results from a section of cohort I participants (https://ibn.fm/156KR). Odyssey’s decision to focus the initial attention of its Phase II clinical trial on the military appears to be a timely intervention aimed at filling gaps in the treatment of concussions among service members. This aligns with its commitment to providing unique, life-saving medical products that deliver clinical advantages to unmet needs. For more information, visit the company’s website at https://odysseygi.com/. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

SPYR Inc. (SPYR) Grows its Footprint and Product Offering with GeoTraq, Inc. Acquisition

  • SPYR just completed the acquisition of GeoTraq as part of its 2022 expansion plan
  • GeoTraq is known for its mission to simplify businesses with mobile IoT by providing low-cost IoT with plug-and-play functionality
  • GeoTraq becomes the second company acquired by SPYR, following Applied Magix’s acquisition in 2020
SPYR (OTCQB: SPYR) recently completed the acquisition of GeoTraq, a Nevada-based enterprise that develops and manufactures advanced Internet of Things (“IoT”) modules for location-based services, asset tracking, and sensor modules for remote monitoring. The acquisition is in line with SPYR 2022 expansion plans to strengthen the company’s balance sheet while also growing shareholder value (https://ibn.fm/rVf2l). Founded back in 2005, GeoTraq made a name for itself in the IoT space, mainly through its mission to simplify businesses with mobile IoT. Driven by its vision for a smart, simple, and connected world, the company has introduced various products, mainly comprised of simple IoT modules that are quick to deploy and easy to maintain. GeoTraq has defined low-cost IoT technology with plug-and-play functionality through its product offerings. Its modules are 100% self-contained, fully integrated, and ultra-small, with a unique design that enables them to connect to sensors, antennas, batteries, and cloud services via GeoTraq’s proprietary cloud-based “WebTraq” platform (https://ibn.fm/mSkpz). “The modules are designed with an event-driven architecture that uses data from sensors to wake up the module to transmit an alert if detection, consumption, or reaction occurs,” notes GeoTraq’s website. “Trigger points are based on conditions, patterns, or readings from sensors; they are intelligently designed to send you only the data you want, at the precise moment you need to act on it,” it adds. GeoTraq becomes SPYR’s second acquisition, following the Applied Magix purchase in 2020. The acquisitions represent the company’s significantly growing footprint and list of products that it offers its consumers. “GeoTraq has built a product that can be used in multiple ways, not just tracking,” noted Tim Matula, SPYR’s Chief Executive Officer (“CEO”). “Sensors can be added to provide the customer with additional data points such as temperature and motion along with other sensor driven data. We are very excited with this acquisition and look forward to continuing to build our company,” he added. For SPYR’s Applied Magix product information, please see the Applied Magix website at https://AppliedMagix.com, or specific product sites: For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

From Our Blog

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Deploying AI for Non-Invasive Intoxication Detection

April 28, 2026

Voice Analytics and AI to Transform Drug and Alcohol Testing Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. The market for workplace drug and alcohol detection is expanding as employers face increasing pressure to improve safety while reducing the cost and friction of traditional testing methods. This creates […]

Rotate your device 90° to view site.